1. Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study.
- Author
-
Maniar, Aesha, Gipson, Debbie S., Brady, Tammy, Srivastava, Tarak, Selewski, David T., Greenbaum, Larry A., Dell, Katherine M., Kaskel, Frederick, Massengill, Susan, Tran, Cheryl, Trachtman, Howard, Lafayette, Richard, Almaani, Salem, Hingorani, Sangeeta, Wang, Chia-shi, Reidy, Kimberly, Cara-Fuentes, Gabriel, Gbadegesin, Rasheed, Myers, Kevin, and Sethna, Christine B.
- Subjects
STEROIDS ,DATA analysis ,SCIENTIFIC observation ,SEX distribution ,DESCRIPTIVE statistics ,AGE distribution ,RITUXIMAB ,NEPHROTIC syndrome ,LONGITUDINAL method ,RESEARCH ,STATISTICS ,GROWTH disorders ,ANTHROPOMETRY ,COMPARATIVE studies ,CONFIDENCE intervals ,REGRESSION analysis ,GLOMERULAR filtration rate ,DISEASE incidence ,CHILDREN - Abstract
Background: Steroids, the mainstay of treatment for nephrotic syndrome in children, have multiple adverse effects including growth suppression. Methods: Anthropometric measurements in children < 18 years enrolled in the Nephrotic Syndrome Study Network (NEPTUNE) were collected. The longitudinal association of medication exposure and nephrotic syndrome characteristics with height z-score and growth velocity was determined using adjusted Generalized Estimating Equation regression and linear regression. Results: A total of 318 children (57.2% males) with a baseline age of 7.64 ± 5.04 years were analyzed. The cumulative steroid dose was 216.4 (IQR 61.5, 652.7) mg/kg (N = 233). Overall, height z-scores were not significantly different at the last follow-up compared to baseline (− 0.13 ± 1.21 vs. − 0.23 ± 1.71, p = 0.21). In models adjusted for age, sex, and eGFR, greater cumulative steroid exposure (β − 7.5 × 10
−6 , CI − 1.2 × 10−5 , − 3 × 10−6 , p = 0.001) and incident cases of NS (vs. prevalent) (β − 1.1, CI − 2.22, − 0.11, p = 0.03) were significantly associated with lower height z-scores over time. Rituximab exposure was associated with higher height z-scores (β 0.16, CI 0.04, 0.29, p = 0.01) over time. Conclusion: Steroid dose was associated with lower height z-score, while rituximab use was associated with higher height z-score. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF